α-synuclein interacts with SOD1 and promotes its oligomerization

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) are debilitating neurodegenerative disorders.
• Alpha-synuclein (α-synuclein) is central to PD pathogenesis, while mutations in Cu, Zn superoxide dismutase (SOD1) are implicated in familial ALS.
• Both α-synuclein and SOD1 can form pathological oligomers and fibrils.

Purpose of the Study:

• To investigate the potential molecular interaction between α-synuclein and SOD1.
• To explore the functional and pathological relevance of this interaction in neurodegeneration.

Main Methods:

• Protein-fragment complementation assay.
• Co-immunoprecipitation (Co-IP).
• Analysis in living cells, human erythrocytes, and mouse brain tissue.

Main Results:

• Demonstrated a physical interaction between α-synuclein and SOD1 in various biological systems.
• Showed that disease-related mutations in both α-synuclein and SOD1 influence their binding.
• Found that α-synuclein accelerates SOD1 oligomerization, irrespective of SOD1's enzymatic activity.

Conclusions:

• Provided evidence for a novel interaction between α-synuclein and SOD1.
• Suggested this interaction may play a role in the pathogenesis of neurodegenerative diseases.